NCT04517552View on ClinicalTrials.gov

Investigation of Inflammation Using [C-11]-CS1P1

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

July 1, 2026

Study Completion Date

July 8, 2026

Conditions
Alzheimer Disease
Interventions
DRUG

[11C]-CS1P1

Participants will receive a single intravenous bolus injection of 6.0 - 20.0 mCi (222-740 MBq) of the investigational radiotracer \[11C\] CS1P1. Participants will then undergo a \[11C\] CS1P1 PET/CT scan.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Tammie L. S. Benzinger, MD, PhD

OTHER